These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9824932)

  • 41. Octreotide in the treatment of refractory ascites of cirrhosis.
    Leong RW; Jeffrey GP
    Scand J Gastroenterol; 2006 Jun; 41(6):763; author reply 764. PubMed ID: 16716981
    [No Abstract]   [Full Text] [Related]  

  • 42. [Octreotide in the treatment of gastrointestinal disorders].
    Jorquera Plaza F; Culebras Fernández JM
    Nutr Hosp; 1996; 11(4):213-4. PubMed ID: 8962900
    [No Abstract]   [Full Text] [Related]  

  • 43. Successful treatment with octreotide of spontaneous chylothorax in a premature infant.
    Coulter DM
    J Perinatol; 2004 Mar; 24(3):194-5. PubMed ID: 15044931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of biliobronchial fistula with octreotide: a case report.
    Petrolati A; Pacella CM; Nasoni S; Rossi Z; Altavilla N; Cipolla R; Fenderico P; Forlini G; Stasi R
    Am J Gastroenterol; 2009 Oct; 104(10):2638-9. PubMed ID: 19806104
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
    Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
    Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is octreotide safe for the management of persistent hyperinsulinemic hypoglycemia of infancy?
    Abdel Khalek M; Kandil E
    Eur J Pediatr Surg; 2011 May; 21(3):188-9. PubMed ID: 21283963
    [No Abstract]   [Full Text] [Related]  

  • 47. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 48. [Changes of somatostatin receptor of pancreas and effectiveness of octreotide on acute necrotizng pancreatitis in mice].
    Wu J; Yuan Y; Xu J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(12):740-3. PubMed ID: 11798959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The potentials for using sandostatin in gastroenterology (a review)].
    Lopatkina TN
    Ter Arkh; 1995; 67(7):66-8. PubMed ID: 7482311
    [No Abstract]   [Full Text] [Related]  

  • 50. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases.
    Perlemuter G; Cacoub P; Chaussade S; Wechsler B; Couturier D; Piette JC
    Arthritis Rheum; 1999 Jul; 42(7):1545-9. PubMed ID: 10403284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Octreotide in the treatment of thoracic duct injuries.
    Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
    Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menetrier's disease: an excellent response to octreotide. A case report from the Middle East.
    Gadour MO; Salman AH; El Samman el Tel W; Tadros NM
    Trop Gastroenterol; 2005; 26(3):129-31. PubMed ID: 16512461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Octreotide therapy for nateglinide-induced hypoglycemia.
    Sherk DK; Bryant SM
    Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
    Gullichsen R
    Tech Coloproctol; 2006 Dec; 10(4):346-9. PubMed ID: 17115310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chylous ascites after pelvic lymph node dissection for gynecologic cancer.
    Williams C; Petignat P; Alobaid A; Provencher D; Gauthier P
    Eur J Surg Oncol; 2007 Apr; 33(3):399-400. PubMed ID: 16682167
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
    Foster E; Leung J
    Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The challenge of treating malignant bowel obstruction.
    J Support Oncol; 2006 Feb; 4(2):83-4. PubMed ID: 16499129
    [No Abstract]   [Full Text] [Related]  

  • 58. Octreotide. Outlook.
    Beglinger C
    Digestion; 1999; 60 Suppl 2():57. PubMed ID: 10357620
    [No Abstract]   [Full Text] [Related]  

  • 59. A decade of octreotide.
    Büchler MW; Beglinger C
    Digestion; 1999; 60 Suppl 2():1. PubMed ID: 10357619
    [No Abstract]   [Full Text] [Related]  

  • 60. Octreotide and its effects on portal circulation.
    Sanyal AJ
    Gastroenterology; 2001 Jan; 120(1):303-5. PubMed ID: 11208741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.